洞察癌症治疗中瘤衍生异构体抑制的方法
Ziwei Tang1, Cheng Chen1, Chen Zhou2
1School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
European journal of medicinal chemistry
|January 17, 2025
概括
瘤衍生异构体 (TDE) 促进癌症的进展和抵抗. 抑制TDE提供了一个有前途的癌症治疗策略,通过准它们的生物发生和分泌途径.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 生物化学 生化学
背景情况:
- 外基因组调解细胞间的通信.
- 瘤衍生的外体 (TDE) 驱动癌症的进展,转移,免疫逃脱和耐药性.
- 抑制TDE是一种潜在的癌症治疗策略.
研究的目的:
- 审查TDE生物发生和分泌机制.
- 讨论用于癌症治疗的小分子TDE抑制剂.
- 为了确定TDE抑制剂开发的障碍和解决方案.
主要方法:
- 对TDE生物发生和分泌途径的文献综述.
- 针对这些途径的小分子TDE抑制剂的分析.
- 讨论TDE抑制剂研究中的挑战和未来方向.
主要成果:
- TDEs对瘤的产生和癌症的进展有显著的贡献.
- 针对TDE生物发生/分泌途径的小分子抑制剂显示出治疗潜力.
- 一些障碍阻碍了TDE抑制剂的临床开发.
结论:
- 理解TDE机制对于开发有效的癌症疗法至关重要.
- 针对TDE提供了一种新的抗癌方法.
- 需要进一步的研究来克服TDE抑制剂开发的挑战.
更多相关视频
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.3K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.1K
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
